Breaking News

Lilly Invests $4.5B in Lilly Medicine Foundry in Indiana

Facility will combine research, manufacturing and technology to optimize manufacturing processes and increase capacity for clinical trial medicines.

By: Kristin Brooks

Managing Editor, Contract Pharma

Eli Lilly and Co. is investing $4.5 billion to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. This facility aims to allow Lilly to research new ways of producing medicines, while also scaling up manufacturing of medicines for clinical trials. The facility combines research and manufacturing in a single location located in Indiana’s LEAP Research and Innovation District in Lebanon, IN. To date, the company has invested more than $13 billion at this site.
 
“As we accelerate our work to discover new medicines for the toughest diseases, we’re continuing to invest in state-of-the-art infrastructure to support our growing pipeline,” said David A. Ricks, Lilly’s chair and CEO. “In addition to supplying high-quality medicine for our clinical studies, this new complex will further strengthen our process development and scale up our manufacturing capabilities to speed delivery of next-generation medicines to patients around the world.”
 
According to the company, The Medicine Foundry will work to further develop new solutions to optimize manufacturing processes and increase capacity for clinical trial medicines, while also reducing costs and environmental impact. The new facility will enable production of various molecular therapies, including drug substances for small molecules, biologics and nucleic acid therapies. New technologies developed at the Medicine Foundry will be transferred to Lilly’s other manufacturing sites for full-scale production. The site’s location in LEAP will support collaboration with Lilly Research Laboratories’ teams in Indianapolis and Lilly’s manufacturing sites in Lebanon.
 
The State of Indiana will support the new site with infrastructure improvements for roads, water, electricity and other utilities. The state will also offer economic incentives tied to Lilly’s investment and employment goals in Lebanon. Once fully operational, the Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers including engineers, scientists, operations personnel and lab technicians.
 
“Lilly’s increased investment in Indiana is creating tremendous new career opportunities for Hoosiers,” said Indiana Secretary of Commerce David Rosenberg. “The LEAP district in Lebanon is quickly becoming an international destination, with $18 billion in committed capital investment on 2,300 acres since its launch in 2022. LEAP and the Hardtech Corridor are attracting global leaders, talent and innovation to Indiana.”


Realted News:

Lilly Invests $1.8B to Expand Manufacturing Footprint in Ireland

Lilly Opens Innovation Center in the Boston Seaport

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters